1 / 2

U.S. Pulmonary Function Testing Systems Market Size & Share

U.S. Pulmonary Function Testing Systems Market

Manisha109
Télécharger la présentation

U.S. Pulmonary Function Testing Systems Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Pulmonary Function Testing Systems Market Analysis The U.S. pulmonary function testing systems market reached $58.4 million in 2022 and is projected to grow at 4.4% CAGR through 2030. Key Market Drivers  Rising asthma prevalence: Cases increased from 24.9 million in 2021 to 26 million in 2022  Shift toward portable testing systems due to lower costs and standard measurement capabilities  Growing awareness of early diagnosis benefits  Increased physician office visits for pulmonary testing, with 5.7 million COPD diagnoses reported in 2021 Market Segments  Type: Portable systems and complete systems, with portable segment showing highest growth  End Users: oHospitals oPhysical examination centers oPhysician groups/clinics oOthers Leading Companies  VYAIRE MEDICAL, INC.  MGC Diagnostics Corporation  KoKo PFT  ndd Medizintechnik AG  COSMED srl Recent Developments  June 2021: KoKo PFT partnered with EirMed for respiratory device manufacturing  June 2021: PulmOne Advanced Medical Devices opened Texas office  August 2019: VYAIRE MEDICAL received FDA clearance for Vyntus ONE and Vyntus BODY systems Market Challenges Cross-contamination risks in system components like rebreathing valves and mouthpieces limit adoption, particularly following COVID-19 concerns. Footnotes

  2. Fortune Business Insights - U.S. Pulmonary Function Testing Systems Market Report https://www.fortunebusinessinsights.com/u-s-pulmonary-function-testing-systems-market-108786

More Related